Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein

Blood

Volumn 90, Issue 9, 1997, Pages 3654-3661

  Frankel, Arthur E ^a   Hall, Philip D ^b   Burbage, Chris ^b   Vesely, Joseph ^b   Willingham, Mark ^b   Bhalla, Kapil ^a   Kreitman, Robert J ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; DIPHTHERIA TOXIN; DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; LEUCINE; PROTEIN;

APOPTOSIS; ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DIAGNOSIS; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RECEPTOR OCCUPANCY;

EID: 0030784767     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3654     Document Type: Article

References (57)

1. Parker S, Tong T, Bolden S, Wingo P: Cancer statistics. 1997. CA Cancer J 47:5, 1997
2. Schiffer C: Acute myeloid leukemia in adults, in Holland J, Frei E, Bast R, Kufe D, Marton D, Weichselbaum R (eds): Cancer Medicine. Philadelphia, PA, Lea & Febiger, 1997, p 2617
3. List A: Role of multidrug resistance and its pharmacological modulation in acute rnyeloid leukemia. Leukemia 10:937, 1996
4. Pirker R, Wallner J, Geissler K, Kinkesch W, Haas O, Bettelheim P, Hopfner M, Scherrer R, Valent P, Havelec L, Ludwig H, Lechner K: MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 83:708, 1991
5. Schneider E, Cowan K, Bader H, Toomey S, Schwrtz G, Karp J, Burke P, Kaufmann S: Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 85:186, 1995
6. Stoetzer O, Nussler V, Darsow M, Gullis E, Pelka-Fleischer R, Scheel U, Wilmanns W: Association of bcl-2, baxs, bc1-xL and interleukin-lβ-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. Leukemia 10:S18, 1996 (suppl 3)
7. Maung Z, MacLean F, Reid M, Pearson A, Proctor S, Hamilton P, Hall A: The relationship between bc1-2 expression and response to chemotherapy in acute leukaemia. Br J Haematol 88:105, 1994
8. Solary E, Witz B, Caillot D, Moreau P, Desablens B, Cahn J, Maloisel F, Sadoun A, Pignon B, Guyotat D, Cassassus P, Ifrah N, Audhuy B, Berthou C, Delain M, Lamy T, Harousseau J: Prospective multicentric randomized study of quinine as a potential MDR-reversing agent for the treatment of acute leukemias. Blood 86:780a, 1995 (abstr, suppl 1)
9. Strom T, Kelley V, Murphy J, Nichols J, Woodworth T: Interleukin-2 receptor-directed therapies: Antibody- or cytokine-based targeting molecules. Adv Nephrol 23:347, 1994
10. Kelleher C, Wong G, Clark S, Schendel P, Minden M, McCulloch E: Binding of iodinated recombinant human GM-CSF to the blast cells of acute myeloblastic leukemia. Leukemia 2:211, 1988
11. Kurata H, Arai T, Yokota T, Arai K: Differential expression of granulocyte-macrophage colony-stimulating factor and IL-3 receptor subunits on human CD34+ cells and leukemic cell lines. J Allergy Clin Immunol 96:1083, 1995
12. Stanley E, Lieschke G, Grail D, Metcalf D, Hodgson G, Gall J, Maher D, Cebon J, Sinickas V, Dunn A: Granulocyte-macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 91:5592, 1994
13. McKinstry W, Li C, Rasko J, Nicola N, Johnson G, Metcalf D: Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89:65, 1997
14. Kreitman RJ, Pastan I: Recombinant toxins containing human GM-CSF and either Pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells. Blood (in press)
15. Murphy J: The diphtheria toxin structural gene. Curr Top Microbiol Immunol 118:235, 1985
16. Choe S, Bennett M, Fujii G, Curmi P, Kantardjieff K, Collier R, Eisenberg D: The crystal structure of diphtheria toxin. Nature 357:216, 1992
17. Naglich J, Metherall J, Russell D, Eidels L: Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor. Cell 69:1051, 1992
18. Gordon V, Kumpel K, Arora N, Henderson M, Leppla S: Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun 63:82, 1995
19. Van Ness BG, Howard JB, Bodley JW: ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products. J Biol Chem 255:10717, 1980
20. Perentesis J, Waddick K, Bendel A, Shao Y, Warman B, Chandan-Langlie M, Uckun FM: Induction of apoptosis in multidrug-resistant and radiation-resistant acute myeloid leukemia cells by a recombinant fusion toxin directed against the human granulecyte macrophage colony-stimulating factor receptor. Clin Cancer Res 3:347, 1997
21. Roy D, Griffin J, Belvin M, Blattler W, Lambert J, Ritz J: Anti-MY9-blocked ricin: An immunotoxin for selective targeting of acute myeloid leukemia cells. Blood 77:2404, 1991
22. Xu Y, Xu Q, Rosenblum M, Scheinberg D: Antileukemic activity of recombinant humanized M195-gelonin immunotoxin in nude mice. Leukemia 10:321, 1996
23. Burbage C, Tagge E, Harris B, Hall P, Fu T, Willingham MC, Frankel AE: Ricin fusion toxin targeted to the human granulocytemacrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells. Leuk Res (in press)
24. Simpson J, Dascher C, Roberts L, Lord J, Balch W: Ricin cytotoxicity is sensitive to recycling between the endoplasmic reticulum and the Golgi complex. J Biol Chem 270:20078, 1995
25. Dalton WT, Ahearn M, McCredie KB, Freireich EJ, Stass SA, Trujillo JM: HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 71:242, 1988
26. Bullock G, Ray S, Reed J, Krajewski S, Ibrado A, Huang Y, Bhalla K: Intracellular metabolism of ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bc1-2 protein. Leukemia 10:1731, 1996
27. L overexpression inhibits taxol-induced Yama protease activity and apoptosis. Cell Growth Differ 7:1087, 1996
28. Qian M, Sanders BG, Kline K: RRR-alphatocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells. Nutrition and Cancer 25:9, 1996
29. Walter M, Cook M, Ealick S, Nagabhushan T, Trotta P, Bugg C: Three-dimensional structure of recombinant human granulocytemacrophage colony-stimulating factor. J Mol Biol 224:1075, 1992
30. Kaushansky K, Shoemaker SG, Alfaro S, Brown C: Hematopoietic activity of granulocyte/macrophage colony-stimulating factor is dependent upon two distinct regions of the molecule: Functional analysis based upon the activities of interspecies hybrid growth factors. Proc Natl Acad Sci USA 86:1213, 1989
31. Kanakura Y, Cannistra SA, Brown CB, Nakamura M, Seelig GF, Prosise WW, Hawkins JC, Kaushansky K, Griffin JD: Identification of functionally distinct domains of human granulocyte-macrophage colony-stimulating factor using monoclonal antibodies. Blood 77:1033, 1991
32. Onetto-Pothier N, Aumont N, Haman A, Park L, Clark SC, De Lean A, Hoang T: IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferation. Leukemia 4:329, 1990
33. Lyne PD, Bamborough P, Duncan D, Richards WG: Molecular modeling of the GM-CSF and IL-3 receptor complexes. Protein Science 4:2223, 1995
34. Rokhlin OW, Griebling TL, Karassina NV, Raines MA, Cohen MB: Human prostate carcinoma cell lines secrete GMCSF and express GMCSF receptors on their cell surfaces. Anticancer Res 16:557, 1996
35. Baldwin GC, Gasson JC, Kaufman SE, Quan SG, Williams RE, Avalos BR, Gazdar AF, Golde DW, DiPersio JF: Nonhematopoietic tumor cells express functional GM-CSF receptors. Blood 73:1033, 1989
36. Young DC, Denetri GD, Ernst TJ, Cannistra SA, Griffin JD: In vitro expression of colony-stimulating factor genes by human acute myeloblastic leukemia cells. Exp Hematol 16:378, 1988
37. Okuda K, Matulonis U, Salgia R, Kanakura Y, Durker B, Griffin JB: Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1. Exp Hematol 22:1111, 1994
38. O'Brien ML, Tew KD: Glutathione and related enzymes in multidrug resistance. Eur J Cancer 32A:967, 1996 (abstr)
39. Re GG, Waters C, Poisson L, Willingham MC, Sugamura K, Frankel AE: Interleukin 2 (IL-2) receptor expression and sensitivity to diphtheria fusion toxin DAB389IL-2 in cultured hematopoietic cells. Cancer Res 56:2590, 1996
40. Sakamaki K, Miyajima I, Kitamura T, Miyajima A: Critical cytoplasmic domains of the common beta subunit of the human GMCSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 11:3541, 1992
41. Griffin JD, Cannistra SA, Sullivan R, Demetri GD, Ernst TJ, Kanakura Y: The biology of GMCSF: Regulation of production and interaction with its receptor. Intern J Cell Cloning 8:35, 1990 (suppl 1)
42. Hallek M, Lepisto EM, Slattery KE, Griffin JD, Ernst TJ: Interferon gamma increases the expression of the gene encoding the beta subunit of the granulocyte-macrophage colony-stimulating factor receptor. Blood 80:1736, 1992
43. Vaux DL, Haecker G, Strasser A: An evolutionary perspective on apoptosis. Cell 76:777, 1994
44. Cotter FE, Johnson P, Hall P, Pocock C, AlMahdi N, Cowell JK, Morgan G: Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. Oncogene 9:3049, 1994
45. Vellenga E, Ostapovicz D, O'Rourke B, Griffin JD: Effects of recombinant IL3, GMCSF, and GCSF on proliferation of leukemic clonogenic cells in short-term and long-term culture. Leukemia 1:584, 1987
46. Hertler A, Schlossman D, Borowitz M, Blythman H, Casellas P, Frankel A: An anti-CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albuminmonensin. Int J Cancer 43:215, 1989
47. Kreitman R, Chaudhary VK, Waldmann T, Willingham MC, FitzGerald DJ, Pastan I: The recombinant immunotoxin anti-Tac (Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia. Proc Natl Acad Sci USA 87:8291, 1990
48. Lozzio BB, Lozzio CB, Bamberger EG, Feliu AS: A multipotential leukemia cell line (K562) of human origin. Proc Soc Exp Biol Med 166:546, 1981
49. Eagle H: Propagination in a fluid medium of a human epidermoid carcinoma, strain KB (21811). Proc Soc Exp Biol Med 89:362, 1955
50. Uzman BG, Foley GE, Farber S, Lazarus H: Morphologic variations in human leukemic lymphoblasts (CCRF-CEM) after long term culture and exposure to chemotherapeutic agents. Cancer 19:1725, 1966
51. Martin P, Papayannopoulou T: HEL cells: A new human erythroleukemia cell line with spontaneous and induced globin expression. Science 216:1233, 1982
52. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human line that proliferates dependently on GM-CSF, IL-3 or erythropoietin. J Cell Physiol 140:323, 1989
53. Sundstrom C, Nilsson K: Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17:565, 1976
54. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K: Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42:1530, 1982
55. Koeffler HP, Golde D: Acute myelogenous leukemia: A human cell line responsive to colony-stimulating activity. Science 200:1153, 1978
56. Lange B, Valtieri M, Santoli D, Caracciolo D, Mavilio F, Gemperlein I, Griffin C, Emanuel B, Finan J, Nowell P, Rovera G: Growth factor requirements of childhood acute leukemia: Establishment of GM-CSF-dependent cell lines. Blood 70:192, 1987
57. Tom BH, Rutsky LP, Jakstys MM, Oyasu R, Kaye CI, Kahan BD: Human colonic adenocarcinoma cells I. Establishment and description of a new line. In Vitro 12:180, 1976